Detalles de la búsqueda
1.
Quality of life with pharmacological treatment in patients with benign prostatic enlargement: results from the Evolution European Prospective Multicenter Multi-National Registry Study.
World J Urol
; 39(2): 517-526, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32367157
2.
Contemporary use of phytotherapy in patients with lower urinary tract symptoms due to benign prostatic hyperplasia: results from the EVOLUTION European registry.
World J Urol
; 39(7): 2661-2667, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33067725
3.
Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis.
World J Urol
; 37(5): 873-878, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30145778
4.
A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group.
Eur J Cancer
; 29A(12): 1672-6, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8398292
5.
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Urology
; 49(3A Suppl): 65-9, 1997 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-9123739
6.
Quantitative assessment of uroflow: is there a circadian rhythm?
Urology
; 50(2): 221-8, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9255292
7.
Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch South East Cooperative Urological Group.
Urology
; 48(6): 894-900, 1996 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-8973673
8.
Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Urology
; 45(4): 581-6, 1995 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-7716838
9.
Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction.
Urology
; 50(1): 55-61, 1997 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-9218019
10.
Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction: a stratified analysis.
Urology
; 49(2): 197-205; discussion 205-6, 1997 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-9037281
11.
Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancer. EORTC GU Group and the Dutch South East Cooperative Urological Group. European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group.
Urology
; 52(3): 403-10, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9730451
12.
[What is the role of neoadjuvant therapy in prostate cancer?]. / Qual è il ruolo della terapia neo-adiuvante nel carcinoma prostatico?
Minerva Urol Nefrol
; 47(4): 209-14, 1995 Dec.
Artículo
en Italiano
| MEDLINE | ID: mdl-8711594
13.
[Prostate cancer]. / Prostaatcarcinoom.
Ned Tijdschr Tandheelkd
; 99(4): 131-3, 1992 Apr.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-11819979
14.
Overview of current status of total androgen deprivation in metastasized prostate cancer.
Eur Urol
; 24 Suppl 2: 67-71, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8262129
15.
Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience.
Mol Urol
; 4(3): 251-6;discussion 257, 2000.
Artículo
en Inglés
| MEDLINE | ID: mdl-11062381
16.
Neoadjuvant therapy in prostate cancer--is it of any use?
Eur Urol
; 24(4): 433-7, 1993.
Artículo
en Inglés
| MEDLINE | ID: mdl-8287884
17.
Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia). The European Tamsulosin Study Group.
Br J Urol
; 80(4): 597-605, 1997 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-9352699
18.
The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT Group.
Eur Urol
; 30(3): 369-76, 1996.
Artículo
en Inglés
| MEDLINE | ID: mdl-8931972
19.
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Semin Urol Oncol
; 14(1 Suppl 1): 10-6, 1996 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8727805
20.
4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer.
Eur Urol
; 38(6): 706-13, 2000 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-11111188